Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

NCT05004129 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Myotonic Dystrophy

Interventions

DRUG: Tideglusib

Sponsor

AMO Pharma Limited